Загрузка...
Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
Introduction. The risk of gastrointestinal (GI) bleeding with rivaroxaban has not been studied extensively. The aim of our study was to assess this risk in comparison to warfarin. Methods. We examined the medical records for patients who were started on rivaroxaban or warfarin from April 2011 to Apr...
Сохранить в:
| Опубликовано в: : | Gastroenterol Res Pract |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4736815/ https://ncbi.nlm.nih.gov/pubmed/26880901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9589036 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|